A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC
Status:
Unknown status
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The aim of this trial is to evaluate the Drug-Drug interaction with Abiraterone combined with
SHR3162 in the Metastatic Castration Resistant Prostate Cancer Patients.